Literature DB >> 28017464

A Review of PAT Strategies in Secondary Solid Oral Dosage Manufacturing of Small Molecules.

Stephan Laske1, Amrit Paudel2, Otto Scheibelhofer2.   

Abstract

Pharmaceutical solid oral dosage product manufacturing is a well-established, yet revolutionizing area. To this end, process analytical technology (PAT) involves interdisciplinary and multivariate (chemical, physical, microbiological, and mathematical) methods for material (e.g., materials, intermediates, products) and process (e.g., temperature, pressure, throughput, etc.) analysis. This supports rational process modeling and enhanced control strategies for improved product quality and process efficiency. Therefore, it is often difficult to orient and find the relevant, integrated aspects of the current state-of-the-art. Especially, the link between fundamental research, in terms of sensor and control system development, to the application both in laboratory and manufacturing scale, is difficult to comprehend. This review compiles a nonexhaustive overview on current approaches from the recognized academia and industrial practices of PAT, including screening, selection, and final implementations in solid oral dosage manufacturing, through a wide diversity of use cases. Finally, the authors attempt to extract a common consensus toward developing PAT application guidance for different unit operations of drug product manufacturing.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Keywords:  Raman spectroscopy; near-infrared spectroscopy; process analytical technology; processing; solid dosage form

Mesh:

Substances:

Year:  2016        PMID: 28017464     DOI: 10.1016/j.xphs.2016.11.011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Benefits of Fractal Approaches in Solid Dosage Form Development.

Authors:  Renata Abreu-Villela; Martin Kuentz; Isidoro Caraballo
Journal:  Pharm Res       Date:  2019-09-06       Impact factor: 4.200

2.  Development of Inline Near-Infrared Spectroscopy Method for Real-Time Monitoring of Blend Uniformity of Direct Compression and Granulation-Based Products at Commercial Scales.

Authors:  Aruna Khanolkar; Bhaskar Patil; Viraj Thorat; Gautam Samanta
Journal:  AAPS PharmSciTech       Date:  2022-08-24       Impact factor: 4.026

3.  NIR Spectroscopy as an Online PAT Tool for a Narrow Therapeutic Index Drug: Toward a Platform Approach Across Lab and Pilot Scales for Development of a Powder Blending Monitoring Method and Endpoint Determination.

Authors:  Sameer Talwar; Pallavi Pawar; Huiquan Wu; Koushik Sowrirajan; Suyang Wu; Benoît Igne; Richard Friedman; Fernando J Muzzio; James K Drennen
Journal:  AAPS J       Date:  2022-09-28       Impact factor: 3.603

Review 4.  Advances in Twin-Screw Granulation Processing.

Authors:  Uttom Nandi; Vivek Trivedi; Steven A Ross; Dennis Douroumis
Journal:  Pharmaceutics       Date:  2021-04-27       Impact factor: 6.321

5.  Feasibility of In-line monitoring of critical coating quality attributes via OCT: Thickness, variability, film homogeneity and roughness.

Authors:  Stephan Sacher; Anna Peter; Johannes G Khinast
Journal:  Int J Pharm X       Date:  2020-12-17

Review 6.  Pharmaceutical application of multivariate modelling techniques: a review on the manufacturing of tablets.

Authors:  Guolin Shi; Longfei Lin; Yuling Liu; Gongsen Chen; Yuting Luo; Yanqiu Wu; Hui Li
Journal:  RSC Adv       Date:  2021-02-23       Impact factor: 3.361

Review 7.  Challenges and Opportunities of Implementing Data Fusion in Process Analytical Technology-A Review.

Authors:  Tibor Casian; Brigitta Nagy; Béla Kovács; Dorián László Galata; Edit Hirsch; Attila Farkas
Journal:  Molecules       Date:  2022-07-28       Impact factor: 4.927

Review 8.  A critical review of recent trends, and a future perspective of optical spectroscopy as PAT in biopharmaceutical downstream processing.

Authors:  Laura Rolinger; Matthias Rüdt; Jürgen Hubbuch
Journal:  Anal Bioanal Chem       Date:  2020-03-07       Impact factor: 4.142

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.